ES2153820T3 - Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones. - Google Patents

Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones.

Info

Publication number
ES2153820T3
ES2153820T3 ES91914348T ES91914348T ES2153820T3 ES 2153820 T3 ES2153820 T3 ES 2153820T3 ES 91914348 T ES91914348 T ES 91914348T ES 91914348 T ES91914348 T ES 91914348T ES 2153820 T3 ES2153820 T3 ES 2153820T3
Authority
ES
Spain
Prior art keywords
benzimidazol
derivatives
procedure
applications
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91914348T
Other languages
English (en)
Inventor
Mark Whittaker
Andrew Miller
Stephen Arthur Bowles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Biotech Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909017878A external-priority patent/GB9017878D0/en
Priority claimed from GB909018040A external-priority patent/GB9018040D0/en
Priority claimed from GB919112214A external-priority patent/GB9112214D0/en
Application filed by British Biotech Pharmaceuticals Ltd filed Critical British Biotech Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES2153820T3 publication Critical patent/ES2153820T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

COMPUESTOS DE FORMULA GENERAL (I) Y SUS SALES DE ADICION ACIDAS E HIDRATOS FARMACEUTICAMENTE Y VETERINARIAMENTE ACEPTABLES SON ANTAGONISTAS DEL FACTOR ACTIVANTE PLAQUETARIO (PAF) Y SU USO EN EL TRATAMIENTO O MINORACION DE VARIAS ENFERMEDADES O DESORDENES MEDIADOS POR EL PAF.
ES91914348T 1990-08-15 1991-08-15 Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones. Expired - Lifetime ES2153820T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909017878A GB9017878D0 (en) 1990-08-15 1990-08-15 Compounds
GB909018040A GB9018040D0 (en) 1990-08-16 1990-08-16 Compounds
GB919112214A GB9112214D0 (en) 1991-06-06 1991-06-06 Compounds

Publications (1)

Publication Number Publication Date
ES2153820T3 true ES2153820T3 (es) 2001-03-16

Family

ID=27265233

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91914348T Expired - Lifetime ES2153820T3 (es) 1990-08-15 1991-08-15 Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones.

Country Status (17)

Country Link
US (1) US5180723A (es)
EP (1) EP0543858B1 (es)
JP (2) JP2976004B2 (es)
KR (1) KR0185959B1 (es)
AT (1) ATE198197T1 (es)
AU (2) AU655595B2 (es)
CA (1) CA2088761C (es)
DE (1) DE69132497T2 (es)
ES (1) ES2153820T3 (es)
FI (1) FI103409B1 (es)
GR (1) GR3035511T3 (es)
HU (1) HUT67289A (es)
IE (1) IE70217B1 (es)
NO (2) NO301228B1 (es)
NZ (1) NZ239409A (es)
PT (1) PT98673B (es)
WO (1) WO1992003423A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT98674B (pt) * 1990-08-15 1999-01-29 British Bio Technology Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de imidazole e de seus intermedriarios
US5274094A (en) * 1990-08-15 1993-12-28 British Bio-Technology Limited Production of heterobicyclic containing benzene sulfonamides
GB9116056D0 (en) * 1991-07-24 1991-09-11 British Bio Technology Compounds
GB9122308D0 (en) * 1991-10-21 1991-12-04 British Bio Technology Compounds
GB9200209D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
GB9200245D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
GB9201755D0 (en) * 1992-01-28 1992-03-11 British Bio Technology Compounds
GB9202791D0 (en) * 1992-02-11 1992-03-25 British Bio Technology Compounds
DE4206042A1 (de) * 1992-02-27 1993-09-02 Bayer Ag Sulfonylbenzyl-substituierte imidazopyridine
DE4327256A1 (de) * 1993-08-13 1995-02-16 Bayer Ag Sulfonylbenzyl-substituierte Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
GB2298138B (en) * 1993-11-10 1997-07-09 British Biotech Pharm 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
GB9323162D0 (en) * 1993-11-10 1994-01-05 British Bio Technology 4-(1h-2-methylimidazo(4,5-c)pyridinylmethyl)phenylsulphonamid e derivatives as antagonists of paf
AU704972B2 (en) 1994-08-04 1999-05-13 H. Lundbeck A/S Novel benzimidazole derivatives
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
DK0790998T3 (da) * 1995-09-08 2001-02-05 Uriach & Cia Sa J Azo-derivater af 5-aminosalicylsyre til behandling af inflammatorisk tarmsygdom
ES2104513B1 (es) * 1995-10-11 1998-07-01 Uriach & Cia Sa J Nuevos derivados del acido 5-aminosalicilico.
ES2106682B1 (es) * 1995-09-08 1998-07-01 Uriach & Cia Sa J Nuevos derivados azo del acido 5-aminosalicilico.
US6495583B1 (en) 1997-03-25 2002-12-17 Synaptic Pharmaceutical Corporation Benzimidazole derivatives
US6858630B2 (en) 1999-12-06 2005-02-22 Smithkline Beecham Corporation Naphthimidazole derivatives and their use as thrombopoietin mimetics
WO2001039773A1 (en) * 1999-12-06 2001-06-07 Smithkline Beecham Corporation Thrombopoietin mimetics
ES2165803B1 (es) 2000-04-10 2003-09-16 Uriach & Cia Sa J Nueva sal de un derivado azo del acido 5-aminosalicilico
WO2003032919A2 (en) * 2001-10-17 2003-04-24 Croda, Inc. Esters of aromatic alkoxylated alcohols and fatty carboxylic acids
TW200303742A (en) 2001-11-21 2003-09-16 Novartis Ag Organic compounds
EP1893569A4 (en) * 2005-06-10 2009-08-05 Elixir Pharmaceuticals Inc SULPHONAMIDE COMPOUNDS AND ITS USES
US7829589B2 (en) * 2005-06-10 2010-11-09 Elixir Pharmaceuticals, Inc. Sulfonamide compounds and uses thereof
RU2453312C1 (ru) * 2010-11-10 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Средство, проявляющее антиагрегантную и антитромбогенную активности
SG2014011209A (en) * 2011-11-23 2014-05-29 Cell Therapy Ltd Platelet lysate gel
GB201321735D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6715600A (es) * 1966-12-02 1968-06-04
US4612323A (en) * 1983-06-27 1986-09-16 Sumitomo Chemical Company, Limited Insecticidal and acaricidal derivatives of 1-benzylbenzimidazole
US4804658A (en) * 1986-09-15 1989-02-14 G. D. Searle & Co. Imidazopyridine derivatives and pharmaceutical compositions
US4914108A (en) * 1988-03-14 1990-04-03 G. D. Searle & Co. 5-substituted(4,5-c)imidazopyridine compounds which have useful platelet activating factor antagonistic activity
DE68920998T2 (de) * 1988-03-15 1995-06-22 Searle & Co 1H/3H-[4-(N,N-CYCLOALKYL UND/ODER VERZWEIGTES ALKYLCARBOXAMIDO)-BENZYL]IMDAZO[4,5-c]PYRIDINE ALS PAF-ANTAGONISTEN.
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
US5157026A (en) * 1989-05-30 1992-10-20 Merck & Co., Inc. Oxo-purines as angiotensin II antagonists
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5274094A (en) * 1990-08-15 1993-12-28 British Bio-Technology Limited Production of heterobicyclic containing benzene sulfonamides
PT98674B (pt) * 1990-08-15 1999-01-29 British Bio Technology Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de imidazole e de seus intermedriarios

Also Published As

Publication number Publication date
AU658337B2 (en) 1995-04-06
NZ239409A (en) 1994-05-26
FI930634A0 (fi) 1993-02-12
IE912875A1 (en) 1992-02-26
JPH11315070A (ja) 1999-11-16
EP0543858B1 (en) 2000-12-20
EP0543858A1 (en) 1993-06-02
DE69132497T2 (de) 2001-06-13
DE69132497D1 (de) 2001-01-25
HK1012336A1 (en) 1999-07-30
ATE198197T1 (de) 2001-01-15
KR0185959B1 (en) 1999-05-01
US5180723A (en) 1993-01-19
FI103409B (fi) 1999-06-30
HUT67289A (en) 1995-03-28
PT98673A (pt) 1992-07-31
JP2976004B2 (ja) 1999-11-10
FI930634L (fi) 1993-04-05
AU655595B2 (en) 1995-01-05
NO301228B1 (no) 1997-09-29
FI103409B1 (fi) 1999-06-30
JPH06500316A (ja) 1994-01-13
HU9300389D0 (en) 1993-04-28
JP3120075B2 (ja) 2000-12-25
IE70217B1 (en) 1996-10-30
NO972615L (no) 1997-06-06
NO972615D0 (no) 1997-06-06
WO1992003423A1 (en) 1992-03-05
AU8426891A (en) 1992-03-17
AU5309094A (en) 1994-03-17
KR930701413A (ko) 1993-06-11
PT98673B (pt) 1999-01-29
NO930498L (no) 1993-04-14
GR3035511T3 (en) 2001-06-29
NO930498D0 (no) 1993-02-12
CA2088761C (en) 1999-11-16
CA2088761A1 (en) 1992-02-16

Similar Documents

Publication Publication Date Title
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
ES2113881T3 (es) Derivados y analogos de acido 2-desoxi-2,3-didehidro-n-acetil neuraminico y su utilizacion como agentes antivirales.
ES2171158T3 (es) Derivados de oxatiolano cristalizados.
ES2075011T3 (es) Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas.
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
PA8432901A1 (es) Compuestos de piridilpirrol
ES2123511T3 (es) Derivados imidazopiridina, procedimiento de preparacion y aplicaciones.
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
IT1224594B (it) Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
ES2058450T3 (es) Compuestos de quinoxalina y su preparacion y uso.
ES2101858T3 (es) Derivados de geneserina como inhibidores de colinesterasa.
ES2038074A1 (es) Nuevos derivados de benzimidazol, su preparacion y su aplicacion como medicamentos.
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
YU78092A (sh) Postupak za dobijanje derivata beta-fenilizoserina i njihova primena
ES2038216T3 (es) Procedimiento para la preparacion de 5-(3-alquil-5-t-butil-4-hidroxi-fenil)-2-amino-6h-1,3,4-tiadazinas y su empleo.
FR2387221A1 (fr) Derives du benzimidazole utilisables comme substances actives de medicaments veterinaires
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
SE8700555L (sv) Purinderivat, deras framstellning och lekemedel innehallande dessa
ES2043515A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-difenilmetilpiperazina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 543858

Country of ref document: ES